This study is a registry, which means it collects information from people who have already received a treatment called unilateral thalamotomy (a brain procedure) using the Exablate Neuro system. This treatment is for people with Parkinson's disease whose tremors are severe and don't respond to medication. The main goal is to see how safe and effective the Exablate Neuro system is over the long term. You can join if you are 30 years or older, have tremor-dominant Parkinson's disease, and are undergoing this specific Exablate procedure as part of your standard care. The study is looking for 50 participants, but the current recruitment status is not available.

Study design

This is an observational study, meaning researchers will collect information from 50 participants who have already received the treatment. It is a post-approval registry.

What's involved

You will have assessments at baseline, 1, 3, 6, and 12 months after your Exablate procedure, and then yearly for five years. These assessments include checking for side effects, medication use, and tremor and Parkinson's disease scales.

Compensation

Not stated in the trial record.

Follow-up

Participants will be followed for five years to track long-term adverse events.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.